FDA bans references to sinusitis on OTC nasal decongestants

10/12/2005 | Wall Street Journal, The

The FDA said OTC nasal decongestants no longer will be allowed to cite "sinusitis" on their products after determining there is no evidence the drugs are effective as a substitute for antibiotics, the normal treatment for a bacterial infection. In addition to drugs for colds and allergies, new regulations also are to apply to topical decongestants and nasal sprays, as well as to combination products and to generic versions of those drugs.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA